Higher prices and weaker US economic growth over the summer are likely to threaten the S&P 500’s rally, according to JPMorgan ...

Recent euro strength, cheaper oil, and the potential hit to economic activity from trade confusion will keep the European Central Bank on an easing path, says Mediolanum International Funds’ Daniel ...

The deal includes a drug for systemic mastocytosis, a rare immunology disease, approved in the U.S. and the European Union under the brand names Ayvakit and Ayvakyt as well as an early-stage ...

MS stock climbs 10.5% in a month. Can it sustain the momentum on strong Asia gains and wealth growth, despite lingering M&A ...